Vitamin D in liver diseases: from mechanisms to clinical trials.
about
Vitamin D supplementation for chronic liver diseases in adultsVitamin D deficiency in patients with liver cirrhosisNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsCationic Polystyrene Resolves Nonalcoholic Steatohepatitis (NASH), Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia.Vitamin D3-induced hypercalcemia increases carbon tetrachloride-induced hepatotoxicity through elevated oxidative stress in mice.Complementary and alternative medications in hepatitis C infection.Can skin exposure to sunlight prevent liver inflammation?Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Hepatitis C virus infection and risk of osteoporosis: A meta-analysis.Bone health and vitamin D status in alcoholic liver disease.Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis.Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study.Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift.Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation.Vitamin D supplementation for chronic liver diseases in adults.Vitamin D3 protects against prednisolone-induced liver injury associated with the impairment of the hepatic NF-κB/iNOS/NO pathway.Normalization of Hepatic Homeostasis in the Npc1nmf164 Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat.Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.
P2860
Q24187784-4001A9C5-59D2-4534-99F4-8D267ACCBF07Q26745766-F6A72594-23C2-4BCB-8388-2A565CE28213Q26796448-C0F92DCC-1199-441D-8643-6F7F65634640Q30401402-B50B5C70-E220-4563-A127-C5DB8A6B7B89Q33611008-FDA1D6E0-9F9D-472B-8AAE-750372A3F920Q34411345-9805EAAA-5E48-48F3-9F04-0230D1155633Q35658038-FCC4EC03-CFA7-4DE7-A972-808A09513842Q35677400-9E194A78-1CDA-4083-8FAE-2F69D6E6A122Q38303313-C6635F40-5DA9-44E5-ADAB-17E7CF7B0D9FQ38672659-D0288E38-3B1D-4CB5-98AB-1554AFD00D1FQ38849637-3C0733B5-56C8-40A3-AFC4-C7782B0768C9Q41306690-4FE35DC8-1BBA-4F9D-95EE-1437C19F5A8EQ44328439-93D136E7-32B2-4BEE-A635-58F03CF35CA8Q47105075-8E79A2C4-5F21-4930-9B43-1DDDD0ED819DQ47547562-F5B4CDDC-59FD-490C-A383-F287ED10A11BQ47663614-204D55EA-5B8D-4C54-9E38-C5B8BB210D15Q47911083-76D79187-AC51-4A75-A558-D0C8A5707134Q48379148-77EBA64D-2E4A-45CC-81A4-66CDC454BAC6Q49722254-F1518DC1-B84B-48E3-B9D1-F8095D2662FF
P2860
Vitamin D in liver diseases: from mechanisms to clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vitamin D in liver diseases: from mechanisms to clinical trials.
@en
type
label
Vitamin D in liver diseases: from mechanisms to clinical trials.
@en
prefLabel
Vitamin D in liver diseases: from mechanisms to clinical trials.
@en
P2093
P2860
P356
P1476
Vitamin D in liver diseases: from mechanisms to clinical trials.
@en
P2093
Hongbo Shi
Longdon Zhu
Sujun Zheng
Yuan-Ping Han
Zhongping Duan
P2860
P356
10.1111/JGH.12016
P478
28 Suppl 1
P577
2013-08-01T00:00:00Z